Using these ANO1-depleted cells, we examined whether the reactivation of ANO1 in response to 5-Aza-CdR treatment could influence the migratory and invasive abilities of prostate cancer cells, which are considered as critical determinants for metastatic cell dissemination. Here, ANO1 is linked to Familial prostate cancer.